Correction to the article “Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity”, published on Acta Med Port 2020 Nov;33(11):761-764
On page 761, in the first sentence of the Introduction, where it reads: ”Cardiovascular Botulinum toxin A (BoNT-A) has been approved for spasticity management.” It should read: “Botulinum toxin A (BoNT-A) has been approved for spasticity management.” Article published with errors: https://www.acta...
Main Author: | Carla de Sousa |
---|---|
Format: | Article |
Language: | English |
Published: |
Ordem dos Médicos
2020-12-01
|
Series: | Acta Médica Portuguesa |
Online Access: | https://actamedicaportuguesa.com/revista/index.php/amp/article/view/15226 |
Similar Items
-
Pharmacoeconomic analysis of the use of botulinum toxin in the treatment of poststroke spasticity
by: A. S. Kolbin, et al.
Published: (2018-05-01) -
The Evaluation of Botulinum Toxin Injection Effect for Poststroke Spasticity Treatment
by: Bekir Enes Demiryurek, et al.
Published: (2017-03-01) -
Different doses of botulinum toxin in spastic equinus foot of poststroke patients
by: Leonardo Halley Carvalho Pimentel
Published: (2013) -
Botulinum therapy for poststroke spasticity of the lower extremity (clinical cases)
by: L. V. Krylova, et al.
Published: (2015-02-01) -
Botulinum toxin treatment of lower extremity spasticity
by: S. E. Khat’kova, et al.
Published: (2017-11-01)